The mission of Organogenesis is to bring the medical marvel of regenerative medicine to patients and standardize its use in everyday medical care.
Initially our corporate mission was to "introduce regenerative medicine to the world." With more than 1 million units of Apligraf® and Dermagraft® - the leading regenerative medicine products in the world - shipped for patient use, we believe that we have successfully achieved this goal.
Across the organization, our mission guides our actions. We work to build brands and services that integrate the benefits of regenerative medicine into every day medical practice.